Jefferies Upgrades Rigel Pharmaceuticals (RIGL) to Buy, 'Strong Commercial Execution'

November 5, 2025 3:45 PM EST Send to a Friend
(Updated - November 5, 2025 3:45 PM EST)

Jefferies analyst Eun Yang upgraded Rigel Pharmaceuticals (NASDAQ: RIGL) from Hold ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login